A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

NCT07723833 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Elecoglipron Reference Formulation Dose A
DRUG: Elecoglipron Test formulation 1 Dose A
DRUG: Elecoglipron Reference Formulation Dose B
DRUG: Elecoglipron Test formulation 1 Dose B
DRUG: Elecoglipron Test formulation 2 Dose A
DRUG: Elecoglipron Test formulation 2 Dose B

Sponsor

AstraZeneca